Long-term outcome and management of complement-mediated thrombotic microangiopathy/aHUS.

This review examines long-term management of complement-mediated thrombotic microangiopathy/aHUS, focusing on complement-inhibitor discontinuation, relapse prediction, and individualized monitoring.